MODIFICATION TO MAMMAPRINT— 510(k) K081092

Substantially Equivalent

Agendia

FDA 510(k) clearance K081092 for MODIFICATION TO MAMMAPRINT, Substantially Equivalent on 2009-12-11. Applicant: Agendia. Device class: 2.

Clearance details

Applicant: Agendia
Product code: Code NYI
Device class: Class 2
Regulation: 21 CFR 866.6040
Advisory panel: Immunology
Date received: 2008-04-17
Decision date: 2009-12-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Amsterdam, NL

Download summary PDF View on FDA.gov ↗

Recent devices under product code NYI

K210973 — MammaPrint FFPE NGS Kit2022-09-08
K201902 — MammaPrint2020-11-05
K141142 — MAMMAPRINT FFPE2015-01-23
K141771 — PROSIGNA BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY2014-11-07
K130010 — PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY2013-09-06

More clearances from Agendia

K101454 — MAMMAPRINT2011-01-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.